Use cases/ Healthcare & Life Sciences/Patients leave appointments with unspoken concerns driving non-compliance
Healthcare & Life Sciences

Patients leave appointments with unspoken concerns driving non-compliance

The patient nodded in the room and then did not follow the plan.

What it costs you today

Your clinical team gives the plan, the patient says they understand, and then they do not follow it. At the next visit you discover they stopped the medication at week two. You do not know if it was side effects, cost, confusion, or something they were embarrassed to say in the room.

How RadRoot is used here

RadRoot sends a five-question adaptive follow-up 48 hours after any care visit where adherence is critical. Questions probe how the patient feels about the plan, what feels hard about it, and whether anything changed since they left the office.

The file you would upload

A athenahealth EHR - Post-Visit Summary Report export. One row is one outpatient visit with treatment plan. RadRoot reads the whole row, so every question can name something the person already knows is true.

Visit IDPatient NamePatient EmailVisit DateProviderPrimary DiagnosisTreatment Plan Type
V-2026-04187Margaret Chenmargaret.chen@northridge-consulting.example.com2026-01-14Dr. Sarah FeldmanType 2 Diabetes MellitusMedication initiation
V-2026-04201James Kowalskij.kowalski@example.org2026-01-15Dr. Michael TorresHypertensionMedication adjustment
V-2026-04229Linda Oseilinda.osei@brighton-motors.example.net2026-01-17Dr. Sarah FeldmanMajor Depressive DisorderMedication initiation
V-2026-04251Robert Baxterrobert.baxter@example.com2026-01-20Dr. Elena RuizHyperlipidemiaMedication initiation
V-2026-04268Priya Sharmapriya.sharma@greenfield-tech.example.com2026-01-21Dr. Michael TorresAsthmaMedication adjustment

First 5 of 20 rows, first 7 of 13 columns. RadRoot interviewed the patient on each row, and 8 of 20 answered.

One interview, exactly as it ran

Six options every time, including the ones that reflect badly on whoever sent it. Each question was written after the answer above it landed.

Q1You started Sertraline 50mg daily for depression on January 17. How has it been going so far?
Q2What made you decide to stop after two days?
Q3Did Dr. Feldman talk with you about possible side effects when you started Sertraline?
Q4Have you let Dr. Feldman know that you stopped the medication?
Q5How do you feel about restarting Sertraline or trying a different approach?

The verdict it produced

Written for whoever ran the campaign. The respondent never sees it.

Linda Osei stopped Sertraline after only two days because she experienced nausea and insomnia and became frightened the side effects would worsen. She does not recall being told these are typical early reactions. She has not yet contacted Dr. Feldman and was planning to wait and see how she felt. She is open to restarting or changing course, but only after a conversation about what to expect. The provider needs to reach out, normalize the early side effects, and reset expectations before adherence can resume.

adherence barrier negative high confidence

The patient discontinued Sertraline after two days due to nausea and insomnia that caused fear of worsening symptoms.

information gap negative medium confidence

The patient does not recall being told that nausea and insomnia are common early side effects of Sertraline.

disclosure reluctance negative high confidence

The patient has not informed the provider that they stopped the medication and planned to wait before doing so.

patient confidence mixed medium confidence

The patient is willing to consider restarting or changing the plan but needs more information from the provider first.

cost barrier positive low confidence

No indication that cost influenced the decision to stop the medication.

See this on your own data

Fifteen minutes, screen to screen. We run your real question through RadRoot while you watch, and you leave with the follow-up it wrote and a price.

Book 15 minutes Answer one yourself